As of 2024-12-11, the Fair Value of Oncolytics Biotech Inc (ONC.TO) is -1.79 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.26 CAD, the upside of Oncolytics Biotech Inc is -242.32%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -17.04 | -33.12 | -22.51 | -26.30 | -24.84 | -24.76 |
| YoY growth | -9.09% | -94.37% | 32.04% | -16.84% | 5.55% | -16.54% |
| Market Cap (mil) | 97.11 |
| P/E | |
| Forward P/E |
| EPS | -0.36 |
| Avg earnings growth rate | -16.54% |
| TTM earnings | -27.64 |